Jennifer Locke
Directeur des opérations chez ClearB Therapeutics, Inc.
Postes actifs de Jennifer Locke
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ClearB Therapeutics, Inc.
 ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Directeur des opérations | - | - |
Adiso Therapeutics, Inc.
 Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Directeur des opérations | 01/01/2022 | - |
| Corporate Officer/Principal | - | - |
Historique de carrière de Jennifer Locke
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
ClearB Therapeutics, Inc.
ClearB Therapeutics, Inc. BiotechnologyHealth Technology ClearB Therapeutics, Inc. is a company that focuses on therapeutics. The company is based in Concord, MA. The company was co-founded in 2017 by Morningside Ventures in collaboration with Professor Stephen Locarnini and the Victoria Infectious Diseases Reference Laboratory. Aileen Rubio has been the CEO of the company since 2018. | Health Technology |
Adiso Therapeutics, Inc.
Adiso Therapeutics, Inc. BiotechnologyHealth Technology Adiso Therapeutics, Inc. creates medicines to treat inflammatory diseases with the goal of improving the lives of patients and their families. Adiso Therapeutics is based in Concord, MA. The company believes that current therapeutic approaches are often inadequate and can pose significant safety concerns for patients. Scott T. Megaffin has been the CEO of the company since 2022. | Health Technology |
- Bourse
- Insiders
- Jennifer Locke
- Expérience
